Edition:
United States

Meridian Bioscience Inc (VIVO.OQ)

VIVO.OQ on NASDAQ Stock Exchange Global Select Market

14.65USD
12:25pm EDT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$14.65
Open
$14.55
Day's High
$14.80
Day's Low
$14.55
Volume
12,773
Avg. Vol
71,694
52-wk High
$16.40
52-wk Low
$13.35

Chart for

About

Meridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain... (more)

Overall

Beta: 0.96
Market Cap(Mil.): $620.34
Shares Outstanding(Mil.): 42.34
Dividend: 0.12
Yield (%): 3.41

Financials

  VIVO.OQ Industry Sector
P/E (TTM): 37.40 38.82 32.94
EPS (TTM): 0.39 -- --
ROI: 7.26 14.37 12.79
ROE: 9.69 17.21 14.67

BRIEF-Meridian Bioscience Reports Q2 GAAP EPS Of $0.12

* MERIDIAN BIOSCIENCE REPORTS SECOND QUARTER 2018 OPERATING RESULTS, DECLARES REGULAR SECOND QUARTER CASH DIVIDEND, AND UPDATES FISCAL 2018 GUIDANCE

Apr 26 2018

BRIEF-Meridian Bioscience Reports Q1 GAAP EPS Of $0.15

* MERIDIAN BIOSCIENCE REPORTS FIRST QUARTER 2018 OPERATING RESULTS, DECLARES REGULAR FIRST QUARTER CASH DIVIDEND, AND REAFFIRMS FISCAL 2018 GUIDANCE

Jan 25 2018

BRIEF-Co-Diagnostics Announces Sale Of Molecular Diagnostic Tests

* CO-DIAGNOSTICS, INC. ANNOUNCES SALE OF MOLECULAR DIAGNOSTIC TESTS, INCLUDING ZIKA VIRUS, TO MAJOR CARIBBEAN LABORATORY Source text for Eikon: Further company coverage:

Dec 12 2017

BRIEF-Meridian Bioscience Files For Mixed Shelf Of Up To $100 Million

* MERIDIAN BIOSCIENCE INC FILES FOR MIXED SHELF OF UP TO $100 MILLION - SEC FILING Source text: (http://bit.ly/2k7rdVf) Further company coverage:

Nov 29 2017

Competitors

Earnings vs. Estimates